mr-kv-venugopalan-president-waters-india

Waters India president: The CRO market is slowing down

  • India
  • |
  • Influencers
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

Waters India, which celebrated its silver jubilee in 2012, is a key player in the separations segment in the India market. The firm is expanding its headquarter... Read more

what-incentives-is-malaysia-offering-to-life-science-firms

What incentives is Malaysia offering to biotech firms?

  • Malaysia
  • |
  • Analysis
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

Malaysia is attracting companies for all over the world to establish their businesses on its shores. The Government of Malaysia and Malaysian Industry Development... Read more

can-anybody-explain-why-life-science-firms-are-making-a-beeline-to-malaysia

Why are bio firms in a hurry to set up shop in Malaysia?...

  • Malaysia
  • |
  • Analysis
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

India-based Agila Biotech, which is a subsidiary of Strides Arcolab, entered into a $34.4 million (RM107 million) build-and-lease agreement with Malaysian Bio-Xcell,... Read more

why-is-the-rate-of-approval-of-biologics-declining-in-india

Approval rate for biologics drop in India

  • India
  • |
  • Analysis
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

The biopharma sector, which contributes about 60 percent of the Indian biotechnology industry, has been witnessing a compound annual growth rate (CAGR) of 21.63... Read more

private-equity-investments-surge-substantially-in-india

Private equity investments rise by 137% in Indian life science...

  • India
  • |
  • Analysis
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

The private equity (PE) investments in the Indian life sciences sector, during 2012 (from January until date), recorded a 137 percent growth as compared to that... Read more

dr-gsk-velu-founder-trivitron-group-of-companies-india

Dr GSK Velu: We are the largest Indian medtech MNC

  • India
  • |
  • Influencers
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

In span of 15 years, Trivitron has emerged as the largest Indian multinational in medical technology with group revenues of $90 million (Rs500 crore) for 2011-12.... Read more

ms-susan-k-finston-co-founder-ceo-and-md-amrita-therapeutics

Amrita develops cancer therapies 'Made in India'

  • Influencers
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

During the mid 2000s, Ms Susan K. Finston along with Dr Ananda M Chakrabarty, were tracking the business opportunities in India, so as to set up a biotech company.... Read more

who-will-win-the-compulsory-licensing-war-alien-bigpharma-or-generic-predators

Compulsory licensing: The debate continues

  • India
  • |
  • Analysis
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

When Indian patent office granted compulsory license to Hyderabad-based Natco Pharma to market a generic version of a patented cancer treatment Nexavar in March... Read more

mr-marc-casper-president-and-ceo-thermo-fisher-scientific-us

Thermo Fisher to grow APAC revenue share to 25%

  • US
  • |
  • Influencers
  • |
  • By Narayanan Suresh
  • |
  • 0 Comment

Thermo Fisher Scientific, a global player in serving science, has revenues of $12 billion and boasts of approximately 39,000 employees worldwide. It serves customers... Read more

mr-lance-little-chairman-and-managing-director-india-and-south-asia-roche-diagnostics

Health awareness is fueling diagnostics in Asia

  • India
  • |
  • Influencers
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche Diagnostics... Read more

trying-to-find-a-solution-for-malaria

New genomes of malaria sequenced, vaccine to follow

  • India
  • |
  • Analysis
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

A group of scientists working in India and the US has sequenced and annotated the genomes of four Plasmodium vivax strains collected from disparate geographic locations... Read more

easypet-3

Eppendorf expands product range in India

  • India
  • |
  • News
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

Bangalore: Eppendorf expanded its tissue culture consumables (TCC) product range with launch of new Easypet 3, cell counting plate and CellRepel TCC in the Indian... Read more

india-biosimilar-guidelines

Biosimilars guidelines: A step in the right direction for...

  • India
  • |
  • Analysis
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

The announcement of the new biosimilars guidelines, "Guidelines on Similar Biologics: Regulatory Requirements for Marketing Authorization in India", by the Indian... Read more

ozone-pharma-offers-chronic-drugs-at-only-4cents-rs2-per-day

BP and Diabetes drugs available at $0.04 per day

  • India
  • |
  • News
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

Bangalore: Considering the rising prices of products and services in India, Ozone Pharmaceuticals, one of the leading prescription drug manufacturing and marketing... Read more

pranab-mukherjee-India's-newest-president

Will biotech get its due in West Bengal?

  • India
  • |
  • Analysis
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

The promise of change swept over West Bengal, a state in the eastern part of India with its capital in Kolkata, in 2011 when Ms Mamata Banerjee of Trinamool Congress... Read more

Previous 1 3 4

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X